Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Xenon Pharmaceuticals Inc., 3 years.
Xenon Pharmaceuticals Inc.
Director
ACADIA Pharmaceuticals Inc.
Director
Alector Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2024 | Alector Inc. | Grant or award | +35,000 | — | — |
| May 29, 2024 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,652 | — | — |
| Mar 8, 2024 | Xenon Pharmaceuticals Inc. | Option exercise | +3,500 | $18.56 | $64,960 |
| Mar 8, 2024 | Xenon Pharmaceuticals Inc. | Shares withheld for tax | −1,408 | $46.16 | $64,993 |
| Mar 8, 2024 | Xenon Pharmaceuticals Inc. | Open-market sale | −2,092 | $45.69 | $95,583 |
| Dec 5, 2023 | Alector Inc. | Gift | −9,459 | — | — |
| Nov 24, 2023 | ACADIA Pharmaceuticals Inc. | Gift | −2,918 | — | — |
| Jun 14, 2023 | Alector Inc. | Grant or award | +26,250 | — | — |
| Jun 1, 2023 | ACADIA Pharmaceuticals Inc. | Option exercise | +8,552 | — | — |
| Sep 29, 2022 | ACADIA Pharmaceuticals Inc. | Option exercise | +1,919 | — | — |
| Jun 7, 2022 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,391 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.